Does IPILIMUMAB Cause Non-small cell lung cancer? 273 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 273 reports of Non-small cell lung cancer have been filed in association with IPILIMUMAB (YERVOY). This represents 0.8% of all adverse event reports for IPILIMUMAB.
273
Reports of Non-small cell lung cancer with IPILIMUMAB
0.8%
of all IPILIMUMAB reports
106
Deaths
97
Hospitalizations
How Dangerous Is Non-small cell lung cancer From IPILIMUMAB?
Of the 273 reports, 106 (38.8%) resulted in death, 97 (35.5%) required hospitalization, and 12 (4.4%) were considered life-threatening.
Is Non-small cell lung cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IPILIMUMAB. However, 273 reports have been filed with the FAERS database.
What Other Side Effects Does IPILIMUMAB Cause?
Death (3,710)
Malignant neoplasm progression (3,296)
Diarrhoea (2,557)
Off label use (2,097)
Colitis (1,988)
Pyrexia (1,796)
Rash (1,556)
Fatigue (1,447)
Intentional product use issue (1,329)
Nausea (1,169)
What Other Drugs Cause Non-small cell lung cancer?
SOTORASIB (483)
CARBOPLATIN (431)
BRIGATINIB (370)
NIVOLUMAB (366)
PACLITAXEL (275)
PEMETREXED (234)
CERITINIB (183)
CRIZOTINIB (178)
AMG-510 (134)
BEVACIZUMAB (118)
Which IPILIMUMAB Alternatives Have Lower Non-small cell lung cancer Risk?
IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE
IPILIMUMAB vs IPRATROPIUM
IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS
IPILIMUMAB vs IPTACOPAN
IPILIMUMAB vs IRBESARTAN